Loading stock data…
Loading stock data…
US$0.95
Get one email when COCP crosses your level. Checked every 15 minutes during market hours.
▼ -0.00 (-0.01%)down today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
37.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.03
Bearish momentumMACD below its signal line (-0.03).
50-day average
1.08
Price belowShort-term trend reference.
200-day average
1.10
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Cocrystal Pharma Inc. is a clinical-stage biotechnology company focused on discovering and developing novel antiviral therapeutics that target the replication process of noroviruses, influenza viruses, coronaviruses including SARS-CoV-2, and rhinoviruses. The company employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. Key programs include CDI-988, an oral direct-acting 3CL protease inhibitor for the treatment and preve…
www.cocrystalpharma.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-07-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-06-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-15 | -0.15 | -0.17 | ✗ Miss |
| 2026-05-06 | 2.55 | 2.72 | ✓ Beat |
| 2026-03-31 | -0.17 | -0.17 | ✓ Beat |
| 2026-02-10 | 0.96 | 1 | ✓ Beat |
| 2026-01-13 | 1.36 | 1.52 | ✓ Beat |
| 2025-11-07 | 0.6 | 0.69 | ✓ Beat |
| 2025-08-14 | -0.3 | -0.2 | ✓ Beat |
Companies in the same industry, via Finnhub